ABSTRACT Dominant mutations of the SOD] gene encoding Cu,Zn superoxide dismutase have been found in members of certain families with familial amyotrophic lateral sclerosis (ALS). To better understand the contribution of SODI mutations in the pathogenesis of familial ALS, we developed transgenic mice expressing one of the mutations found in familial ALS. These animals display clinical and pathological features closely resembling human ALS. Early changes observed in these animals were intra-axonal and dendritic vacuoles due to dilatation of the endoplasmic reticulum and vacuolar degeneration of mitochondria. We have reported that the Golgi apparatus of spinal cord motor neurons in patients with sporadic ALS is fragmented and atrophic. In this study we show that spinal cord motor neurons of transgenic mice for an SODI mutation display a lesion of the Golgi apparatus identical to that found in humans with sporadic ALS. In these mice, the stacks of the cisternae of the fragmented Golgi apparatus are shorter than in the normal organelle, and there is a reduction in Golgi-associated vesicles and adjacent cisternae of the rough endoplasmic reticulum.
pathological features closely resembling human ALS. Early changes observed in these animals were intra-axonal and dendritic vacuoles due to dilatation of the endoplasmic reticulum and vacuolar degeneration of mitochondria. We have reported that the Golgi apparatus of spinal cord motor neurons in patients with sporadic ALS is fragmented and atrophic. In this study we show that spinal cord motor neurons of transgenic mice for an SODI mutation display a lesion of the Golgi apparatus identical to that found in humans with sporadic ALS. In these mice, the stacks of the cisternae of the fragmented Golgi apparatus are shorter than in the normal organelle, and there is a reduction in Golgi-associated vesicles and adjacent cisternae of the rough endoplasmic reticulum. Furthermore, the fragmentation of the Golgi apparatus occurs in an early, presymptomatic stage and usually precedes the development of the vacuolar changes. Transgenic mice overexpressing the wild-type human superoxide dismutase are normal. In familial ALS, an early lesion of the Golgi apparatus of motor neurons may have adverse functional effects, because newly synthesized proteins destined for fast axoplasmic transport pass through the Golgi apparatus.
Amyotrophic lateral sclerosis (ALS) is a fatal degenerative disease, which in the classical sporadic form is characterized by the involvement of both upper and lower motor neurons and pyramidal tract degeneration (1, 2) . About 10% of cases of ALS are familial and these are characterized by additional pathological features that include involvement of sensory fibers in the posterior columns as well as cerebellar projections in the lateral columns (2, 3) . Until recently there were no clues concerning the etiology and pathogenesis of the degeneration and death of motor neurons in ALS. Now, a percentage of patients with familial ALS has been identified as carrying one of several missense mutations in the gene for Cu,Zn superoxide dismutase (SOD) (4) (5) (6) . Cu,Zn SOD is a metalloenzyme that catalyzes the dismutation of superoxide anion (O-) to hydrogen peroxide (H202) (7, 8) . The gene is located on chromosome 21 and consists of five exons. No deletions of the Cu,Zn SOD gene have been identified in any of the families examined so far. This strongly suggests that the expression of the mutant enzyme is necessary for the pathogenesis of the disease.
To test this hypothesis, in 1994, Gurney et al. (9) generated transgenic mice expressing a mutant form of Cu,Zn SOD, which was identified in one of the families with familial ALS. The selected mutation was in exon 4 of the SOD gene and produced a Gly -> Ala change at position 93 (G93A) of the enzyme. Multiple lines of transgenic mice carrying this mutation have now developed severe motor impairment. Clinical and pathological studies have shown a pattern of disease that, in many respects, and especially in its late phases, is very similar to that in familial ALS (9) (10) (11) (12) . In fact, whereas initial alterations in these mice are mainly characterized by vacuolar changes in axons, dendrites, and cell bodies of motor neurons, later the alterations consist of anterior horn neuronal loss ("50%), neuronal atrophy, axonal swellings with filamentous accumulations, and the presence of cytoplasmic inclusions, closely reminiscent of the Lewy-like bodies described in humans with familial ALS (3, 10, 11) . Importantly, mice transgenic for the wild-type form of human SOD and expressing comparable levels of protein and enzyme activity to that seen in mice transgenic for the mutant form never developed clinical disease, and, pathologically, changes remained very subtle and were limited to mild cytoplasmic vacuolization, mainly in motor axons (11) . The late pattern of disease, characterized by neuronal loss, never developed in mice overexpressing the wild-type human transgene. These data strongly support the hypothesis that pathological changes in this murine model of familial ALS are due to a new toxic function exerted by the mutant enzyme, rather than to loss of enzyme activity due to a dominant negative effect (9) (10) (11) (12) .
The cellular target or targets of the presumed toxic effect of the SOD mutations are not known, but significant insights have been gained from ultrastructural studies of degenerating neurons in these transgenic mice. Among the ultrastructural changes observed in mice expressing the mutant SOD transgene, the most readily notable were dilatation of the cisternae of the endoplasmic reticulum and peculiar alterations in mitochondria leading to swelling and linearization of their architecture to form long, curled membranous profiles (10, 11, 13) . These changes accounted for most of the vacuolar changes that were observed in the first phase of the disease. In addition to these changes, however, there were also more subtle alterations of the Golgi cisternae, mainly consisting of their dilatation and apparent disorganization (11) .
In patients with sporadic ALS, the Golgi apparatus of motor neurons, studied with an organelle-specific antiserum, is fragmented (14) (15) (16) (17) (18) . This organelle-specific antiserum reacts with MG160, a conserved membrane sialoglycoprotein of the medial cisternae of the Golgi apparatus (19) . MG160 has been cloned and sequenced, and the gene for MG160 has been Abbreviations: ALS, amyotrophic lateral sclerosis; SOD, superoxide dismutase; RER, rough endoplasmic reticulum. §To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 5473 assigned to the long arm of chromosome 16 (20, 21) . Furthermore, developmental studies in chicken embryos have shown that MG160 is a primordial protein of the Golgi apparatus, appearing very early in development (22) .
The fragmentation of the Golgi apparatus of motor neurons in ALS resembles a similar change of the organelle induced by drugs that disrupt microtubules (23, 24) . Furthermore, all neurons containing ubiquitin-positive inclusions, thought to be pathognomonic for ALS (25) , had fragmented Golgi apparatus (17) . For these reasons it was proposed that a valid animal model for ALS should be associated with a fragmented Golgi apparatus of motor neurons. Such Golgi pathology may be important to explain, at least in part, the process leading to neuronal death in these patients, because the experimental fragmentation of the organelle has been associated with significant impairment of secretion (26) (27) (28) . Furthermore, the Golgi apparatus is involved in numerous important functions such as the transport, processing, and targeting of virtually all proteins synthesized in the rough endoplasmic reticulum (RER) and is destined for the secretory pathways, the plasma membrane, or lysosomes (29, 30) . Specifically in neurons, all newly synthesized proteins destined for fast axoplasmic transport pass through the Golgi apparatus (31) .
In the present study we asked whether human SOD transgenic mice show an alteration of the Golgi apparatus similar to that seen in patients with sporadic ALS. In addition, we examined whether changes in the Golgi apparatus might occur early in the disease process, thus possibly being implicated in the pathogenesis of the neuronal dysfunction. Such questions cannot be answered from human studies, because examination of the central nervous system from ALS patients is generally done at the terminal stages of the disease. Finally, we asked the question whether alterations of the Golgi apparatus were dependent on the expression of the mutant enzyme or they could be produced by the overexpression of the wild-type form of human SOD.
MATERIALS AND METHODS
The production of transgenic mice, assessment of levels of SOD protein and enzyme activity, and clinical assessment of neurological disease have already been reported (9) (10) (11) (12) . Also reported have been both clinical and pathological changes in transgenic mice at different ages. Briefly, the first pathological alterations in the cytoplasm of motor neurons of mutant transgenic animals were seen at '60 days, while the first clinical abnormalities were observed at "80 days. In mice overexpressing the wild-type human transgene, clinical signs never developed, and only subtle alterations in the motor axons were observed at later time points.
Guided by those earlier findings, in this study, we selected mice expressing the mutant transgene and mice overexpressing the wild-type transgene, both at different ages from 31 days to 289 days. At least two animals were sacrificed per time point. For morphometric analysis, four mutant and four overexpressor transgenic animals were selected at -100 days of age.
Preparation of Tissues for Light Microscopy Immunohis- tochemistry. Mice were perfused with phosphate-buffered physiologic saline (PBS), pH 7.35, at room temperature. Perfusion was continued with -50 ml of freshly prepared 1% paraformaldehyde in PBS. The spinal cord was removed, cut into 2-to 3-mm cross sections, kept in the same fixative at room temperature for 6-8 hr, and processed as previously described (32) .
Morphometry and Statistical Methodology. Morphometric studies were done with a CUE-2 image analyzer using the planomorphometry program according to a previously described protocol (Olympus, Lake Success, NY) (17) . Mean surface area of neurons, their mean nuclear area, the area of the immunostained Golgi apparatus per neuron, the number of As previously reported, the first changes observed in motor neurons of transgenic mice at both light and ultrastructural levels consist of vacuolization of motor axons, followed by the neuronal cytoplasm and dendrites (10, 11) . Vacuoles derive from swellings of both the cisternae of the endoplasmic reticulum and, especially, mitochondria, which eventually transform into linear or curved membranous arrays.
In paraffin sections from all animals examined in this study, we did not observe vacuolization of the neuronaI cytoplasm without fragmentation of the Golgi apparatus, whereas fragmentation of this organelle was frequently observed in neurons without apparent cytoplasmic vacuolization. As shown in Table 1 (Fig. 2) .
Additional morphometric analyses were done in the above mutant transgenic mice and in mice overexpressing wild-type human SOD, at comparable ages ( to two medial cisternae of the Golgi stacks, flanked by [1] [2] [3] unstained cistemae (Figs. 3-5 ). The Golgi apparatus from normal-appearing spinal cord motor neurons was found in the proximity of the RER, and consisted of the usual stacks of 5-7 cisternae, which were surrounded by numerous unstained smooth vesicles (Figs. 3 and 4) . The elements of the fragmented Golgi apparatus were detected at the margins of cytoplasmic vacuoles. The stacks of the cisternae were shorter than in the normal-appearing Golgi, and there was a reduction of Golgi-associated unstained vesicles, while neighboring RER was scanty or absent (Fig. 5) . The adjacent cytoplasmic vacuoles were partially enclosed by remnants of membranes, the origins of which could not be determined (Fig. 5 ).
DISCUSSION
We have suggested that fragmentation of the Golgi apparatus is an early response of motor neurons to injury during the development of ALS and in certain motor neuropathies (14) (15) (16) (17) (18) . However, it was difficult to discern in those human studies whether such Golgi alterations represented a terminal event in a dying neuron or earlier changes contributing significantly to the process of neuronal degeneration. Time-course studies to explore whether changes of the Golgi apparatus are indeed early events in ALS and related diseases are, obviously, not possible in humans, although it would be possible in an appropriate animal model. Our transgenic model with expression of a mutant form of Cu,Zn SOD, identified in one of the families with familial ALS, gave us the perfect opportunity to look into this important question.
Cu,Zn SOD is an important enzyme in the cascade of events leading to the neutralization of injurious oxygen radicals in tissues. Its main function is to scavenge superoxide anion (O°) into hydrogen peroxide (H202), which is then decomposed to water by glutathione peroxidase. How mutant human Cu,Zn SOD damages motor neurons is unclear, but most hypotheses propose that damage is mediated by free radicals. Hypotheses include the generation of hydroxyl radical (34) , the catalysis of peroxynitrite-mediated nitration of proteins (35) , and the release of free copper, which might then catalyze oxidative damage to lipids and proteins. For example, mutation may alter the capacity of the enzyme to catalyze free radical formation or may promote nitration reactions. Superoxide reacts with nitric oxide (NO) to form peroxynitrite anion (ONOO-). The reaction of mutant Cu,Zn SOD with ONOOmay promote formation of toxic nitronium intermediates, which would produce unwanted nitration of proteins (35, 36) . Thus, either lipid peroxidation promoted by free radical This study shows fragmentation of the Golgi apparatus of spinal cord neurons in mutant transgenic mice with an identical pattern to that observed in patients with ALS. In addition, this study strongly suggests that the Golgi apparatus may be one of the earliest targets of the SOD mutation. Two features support this contention. First, the fragmentation of the Golgi apparatus was seen in asymptomatic animals. Second, while virtually all neurons with vacuolar changes contained fragmented Golgi apparatus, many neurons with fragmented Golgi had no vacuolar changes. These data strongly suggest that the alterations of the Golgi apparatus usually precede the vacuolar changes in motor neurons of transgenic animals. The discovery of lesions in the Golgi apparatus at very early times in the mutant transgenics, before the development of any other pathological or clinical evidence of disease, is potentially important. The Golgi apparatus is a crucial component of the cell, because it is involved in the transport and processing of polypetpides as well as in their targeting to different destinations, such as plasma membranes and lysosomes, and to their secretion (29, 30) . Previous studies with ALS patients had suggested that fragmentation of a structure with such crucial roles in the cellular handling of proteins was likely to be associated with significant impairment of function. The new immunoultrastructural data of this study support this hypothesis. Specifically, the paucity of vesicles in the vicinity of the shortened Golgi cisternae (Fig. 5) imply an impairment of molecular traffic between Golgi cisternae and from the Golgi apparatus to the periphery-i.e., along dendrites, axons, and presynaptic terminals. It is quite possible that membranes of the Golgi apparatus, or key proteins mediating the anchorage of Golgi membranes with microtubules, may be early targets of the toxic function of the mutated SOD protein (23, 24, 37) . The first experimental observation on the role of microtubules in the structural organization of the Golgi complex, made more than 30 years ago, has been confirmed and followed by many studies from several laboratories (23, 38) . However, the mechanism or mechanisms for the interdependence between the Golgi apparatus and microtubules are still poorly understood. Turner and Tartakoff (24) suggested that the dispersion of the Golgi apparatus in colchicine-treated cells may be caused by the disruption of the normal tubular interconnections between the groups of Golgi stacks. A close comparison between the fine structure of the fragmented Golgi apparatus in the SOD mouse and reports on the effects of microtubule-disrupting agents on the Golgi apparatus in other cells or of the mitotic form of the Golgi apparatus reveal certain similarities but also some differences that may be significant. For example, in colchicine-treated pancreatic acinar cells and mitotic FT210 cells, the cisternae of the Golgi stacks are shorter than in normal cells, as in Fig. 5 . However, mutant SOD mice did not contain the large groups of small vesicles near the Golgi elements observed in colchicine-treated and mitotic cells (39, 40) . An apparent fragmentation of the Golgi apparatus does not necessarily imply depolymerization of microtubules. The microtubules may be intact, but the molecular linkages between the membranes of the Golgi apparatus and the microtubules may be impaired.
An apparent fragmentation of the Golgi apparatus may also be the result of an accentuated retrograde flow of Golgi membranes from the Golgi apparatus to the RER, while the orthograde flow of membranes from the RER to the Golgi apparatus is blocked or diminished. This hypothesis is supported by several experiments that suggest that there exists a physiologic retrograde traffic of membranes from distal to proximal components of the Golgi apparatus or into the RER (40) (41) (42) (43) . It is conceivable, therefore, that the inhibition of another microtubule-associated motor molecule promoting a RER-to-Golgi apparatus transport might result in the accumulation of Golgi molecules into the RER, thus producing the immunocytochemical image of fragmented or dispersed Golgi apparatus.
It is unlikely that the fragmentation of the Golgi apparatus is due to a Brefeldin A-like effect of the mutant proteins (44, 45) . In Brefeldin A-treated cells, the Golgi stacks are disrupted, while they are present here (Fig. 5) ; furthermore, in Brefeldin A-treated cells, proteins of the Golgi apparatus are redistributed in the RER including the nuclear envelope, which was never observed in sporadic ALS or in these transgenic mice (14-18, 40, 46) .
Whereas vacuoles in the cytoplasm of motor neurons and processes have been found in human SOD transgenic mice, these changes have not been reported in human ALS, although they have been observed in motor neurons in tetanus, in which oxidative stress has been postulated as a causative factor (47) . However, vacuoles are predominantly a feature of the early phase of disease in the Gl line of mice which have relatively high levels of expression of the human transgene. Animals with lower expression of the transgene, such as the G20 and G5 lines of animals, only show minimal vacuolar changes. These animals-i.e., the G20 (9-11) and G5 lines (unpublished data)-survive long enough to develop a pattern of disease which is characterized by neuronal loss, atrophy of anterior horns, and filamentous inclusions. These changes are essentially identical to those in human ALS, particularly the familial form (48, 49) . Therefore, it is quite possible that in humans with ALS, if there is indeed an early phase of vacuolar changes, these are modest and more similar to those in transgenic mice with intermediate levels of expression of the mutant transgene. Furthermore, it is likely that the vacuolar phase would go undetected because, in ALS patients, the examination of the central nervous system is generally performed at the end stage of the disease process.
Another significant result of this study is that mice overexpressing the wild-type human SOD fail to develop fragmentation of the Golgi apparatus as late as 289 days after birth. This observation is consistent with the conclusion that the fragmentation of the Golgi apparatus in SOD transgenic mice is dependent on the presence of the mutant enzyme. This supports the gain of function hypothesis for the pathogenesis of mutant SOD-induced cellular injury in this animal model of ALS.
